Vanda Pharmaceuticals (VNDA) Change in Acquisitions & Divestments (2010 - 2026)

Vanda Pharmaceuticals has disclosed Change in Acquisitions & Divestments across 17 years of filings, most recently posting $30.5 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $30.5 million, down 65.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $151.0 million (down 60.18% YoY), and the FY2025 annual result was $208.2 million, down 40.85% from the prior year.
• Change in Acquisitions & Divestments came in at $30.5 million for Q1 2026 at Vanda Pharmaceuticals, down from $47.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $350.4 million in Q1 2023 to a low of $30.5 million in Q1 2026.
• The 5-year median for Change in Acquisitions & Divestments is $82.5 million (2022), against an average of $93.7 million.
• Across the five-year window, Change in Acquisitions & Divestments soared 289.0% in 2023 and sank 82.73% in 2024, its largest moves.
• Vanda Pharmaceuticals' Change in Acquisitions & Divestments stood at $80.0 million in 2022, then jumped by 40.14% to $112.1 million in 2023, then retreated by 13.83% to $96.6 million in 2024, then tumbled by 51.35% to $47.0 million in 2025, then plunged by 35.2% to $30.5 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $30.5 million (Q1 2026), $47.0 million (Q4 2025), and $35.6 million (Q3 2025), per Business Quant data.